Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity

L A Daniëls; S Oerlemans; A D G Krol; C L Creutzberg; L V van de Poll-Franse

doi:10.1038/bjc.2013.779

journal article Jan 16, 2014

Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity

L A Daniëls S Oerlemans A D G Krol C L Creutzberg L V van de Poll-Franse

British Journal of Cancer Vol. 110 No. 4 pp. 868-874 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/bjc.2013.779

Topics

No keywords indexed for this article. Browse by subject →

References

39

[1]

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

N. K. Aaronson, S. Ahmedzai, B. Bergman et al.

JNCI Journal of the National Cancer Institute 1993 10.1093/jnci/85.5.365

[2]

Aleman BM, van den Belt-Dusebout AW, Klokman WJ, Van’t Veer MB, Bartelink H, van Leeuwen FE (2003) Long-term cause-specific mortality of patients treated for Hodgkin’s disease. J Clin Oncol 21 (18): 3431–3439. 10.1200/jco.2003.07.131

[3]

Berger AM, Gerber LH, Mayer DK (2012) Cancer-related fatigue: implications for breast cancer survivors. Cancer 118 (8 Suppl): 2261–2269. 10.1002/cncr.27475

[4]

The validity of the Hospital Anxiety and Depression Scale

Ingvar Bjelland, Alv A Dahl, Tone Tangen Haug et al.

Journal of Psychosomatic Research 2002 10.1016/s0022-3999(01)00296-3

[5]

Cella D, Davis K, Breitbart W, Curt G (2001) Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19 (14): 3385–3391. 10.1200/jco.2001.19.14.3385

[6]

Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM (2011) Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol 29 (1): 89–96. 10.1200/jco.2010.28.0107

[7]

Cramp F, Byron-Daniel J (2012) Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 11: CD006145.

[8]

De Backer IC, Vreugdenhil G, Nijziel MR, Kester AD, van BE, Schep G (2008) Long-term follow-up after cancer rehabilitation using high-intensity resistance training: persistent improvement of physical performance and quality of life. Br J Cancer 99 (1): 30–36. 10.1038/sj.bjc.6604433

[9]

De Bruin ML, Sparidans J, Van’t Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, van den Berg H, Russell NS, Broeks A, Baaijens MH, Aleman BM, van Leeuwen FE (2009) Breast cancer risk in female survivors of Hodgkin’s lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 27 (26): 4239–4246. 10.1200/jco.2008.19.9174

[10]

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

Andreas Engert, Heinz Haverkamp, Carsten Kobe et al.

The Lancet 2012 10.1016/s0140-6736(11)61940-5

[11]

Engert A, Plutschow A, Eich HT, Lohri A, Dorken B, Borchmann P, Berger B, Greil R, Willborn KC, Wilhelm M, Debus J, Eble MJ, Sokler M, Ho A, Rank A, Ganser A, Trumper L, Bokemeyer C, Kirchner H, Schubert J, Kral Z, Fuchs M, Muller-Hermelink HK, Muller RP, Diehl V (2010) Reduced treatment intensity in patients with early-stage Hodgkin’s lymphoma. N Engl J Med 363 (7): 640–652. 10.1056/nejmoa1000067

[12]

Flechtner H, Ruffer JU, Henry-Amar M, Mellink WA, Sieber M, Ferme C, Eghbali H, Josting A, Diehl V (1998) Quality of life assessment in Hodgkin’s disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D’Etude des Lymphomes de L’Adulte and German Hodgkin Study Group. Ann Oncol 9 (Suppl 5): S147–S154. 10.1093/annonc/9.suppl_5.s147

[13]

Fobair P, Hoppe RT, Bloom J, Cox R, Varghese A, Spiegel D (1986) Psychosocial problems among survivors of Hodgkin’s disease. J Clin Oncol 4 (5): 805–814. 10.1200/jco.1986.4.5.805

[14]

Heutte N, Flechtner HH, Mounier N, Mellink WAM, Meerwaldt JH, Eghbali H, Van’t Veer MB, Noordijk EM, Kluin-Nelemans JC, Lampka E, Thomas J, Lugtenburg PJ, Viterbo L, Carde P, Hagenbeek A, van der Maazen RWM, Smit WGJM, Brice P, Kooy MV, Baars JW, Poortmans P, Tirelli U, Leeksma OC, Tomsic R, Feugier P, Salles G, Gabarre J, Kersten MJ, Van Den Neste E, Creemers GJM, Gaillard I, Meijnders P, Tertian G, Reman O, Muller HP, Troncy J, Blanc M, Schroyens W, Voogt PJ, Wijermans P, Rieux C, Ferme C, Henry-Amar M (2009) Quality of life after successful treatment of early-stage Hodgkin’s lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol 10 (12): 1160–1170. 10.1016/s1470-2045(09)70258-x

[15]

Hjermstad MJ, Fossa SD, Oldervoll L, Holte H, Jacobsen AB, Loge JH (2005) Fatigue in long-term Hodgkin’s disease survivors: A follow-up study. J Clin Oncol 23 (27): 6587–6595. 10.1200/jco.2005.09.936

[16]

Joly F, HenryAmar M, Arveux P, Reman O, Tanguy A, Peny AM, Lebailly P, MaceLesech J, Vie B, Genot JY, Busson A, Troussard X, Leporrier M (1996) Late psychosocial sequelae in Hodgkin’s disease survivors: A French population-based case-control study. J Clin Oncol 14 (9): 2444–2453. 10.1200/jco.1996.14.9.2444

[17]

Kangas M, Bovbjerg DH, Montgomery GH (2008) Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull 134 (5): 700–741. 10.1037/a0012825

[18]

Knobel H, Loge JH, Lund MB, Forfang K, Nome O, Kaasa S (2001) Late medical complications disease and fatigue in Hodgkin’s disease survivors. J Clin Oncol 19 (13): 3226–3233. 10.1200/jco.2001.19.13.3226

[19]

Kuhnt S, Ernst J, Singer S, Ruffer JU, Kortmann RD, Stolzenburg JU, Schwarz R (2009) Fatigue in cancer survivors—prevalence and correlates. Onkologie 32 (6): 312–317. 10.1159/000215943

[20]

Loge JH, Abrahamsen AF, Ekeberg O, Hannisdal E, Kaasa S (1997) Psychological distress after cancer cure: a survey of 459 Hodgkin’s disease survivors. Br J Cancer 76 (6): 791–796. 10.1038/bjc.1997.464

[21]

Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S (1999) Hodgkin’s disease survivors more fatigued than the general population. J Clin Oncol 17 (1): 253–261. 10.1200/jco.1999.17.1.253

[22]

Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S (2000) Fatigue and psychiatric morbidity among Hodgkin’s disease survivors. J Pain Sympt Manag 19 (2): 91–99. 10.1016/s0885-3924(99)00148-7

[23]

Michielsen HJ, De VJ, Drent M, Peros-Golubicic T (2005) Psychometric qualities of the Fatigue Assessment Scale in Croatian sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 22 (2): 133–138.

[24]

Michielsen HJ, De VJ, Van Heck GL (2003) Psychometric qualities of a brief self-rated fatigue measure: the Fatigue Assessment Scale. J Psychosom Res 54 (4): 345–352. 10.1016/s0022-3999(02)00392-6

[25]

Miltenyi Z, Magyari F, Simon Z, Illes A (2010) Quality of life and fatigue in Hodgkin’s lymphoma patients. Tumori 96 (4): 594–600. 10.1177/030089161009600413

[26]

Mols F, AJJM Vingerhoets, Coebergh JW, Vreugdenhil G, Aaronson NK, Lybeert MLM, de Poll-Franse LVV (2006) Better quality of life among 10-15 year survivors of Hodgkin’s lymphoma compared to 5-9 year survivors: a population-based study. Eur J Cancer 42 (16): 2794–2801. 10.1016/j.ejca.2006.08.006

[27]

Ng AK, Li S, Recklitis C, Neuberg D, Chakrabarti S, Silver B, Diller L (2005) A comparison between long-term survivors of Hodgkin’s disease and their siblings on fatigue level and factors predicting for increased fatigue. Ann Oncol 16 (12): 1949–1955. 10.1093/annonc/mdi407

[28]

Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41 (5): 582–592.

[29]

Oerlemans S, Mols F, Nijziel MR, Lybeert M, van de Poll-Franse L (2011) The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin’s and non-Hodgkin’s lymphoma survivors: a systematic review. Ann Hematol 90 (9): 993–1004. 10.1007/s00277-011-1274-4

[30]

Ruffer JU, Flechtner H, Tralls P, Josting A, Sieber M, Lathan B, Diehl V (2003) Fatigue in long-term survivors of Hodgkin’s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer 39 (15): 2179–2186. 10.1016/s0959-8049(03)00545-8

[31]

Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN (2003) The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 49 (2): 156–163. 10.1002/art.10993

[32]

Schultz SL, Dalton SO, Christensen J, Carlsen K, Ross L, Johansen C (2011) Factors correlated with fatigue in breast cancer survivors undergoing a rehabilitation course, Denmark, 2002-2005. Psychooncology 20 (4): 352–360. 10.1002/pon.1739

[33]

Snaith RP, Zigmond AS (1986) The hospital anxiety and depression scale. Br Med J (Clin Res Ed) 292 (6516): 344. 10.1136/bmj.292.6516.344

[34]

van de Poll-Franse LV, Horevoorts N, van EM, Denollet J, Roukema JA, Aaronson NK, Vingerhoets A, Coebergh JW, De VJ, Essink-Bot ML, Mols F (2011a) The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer 47 (14): 2188–2194. 10.1016/j.ejca.2011.04.034

[35]

van de Poll-Franse LV, Mols F, Gundy CM, Creutzberg CL, Nout RA, Verdonck-de Leeuw IM, Taphoorn MJ, Aaronson NK (2011b) Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer 47 (5): 667–675. 10.1016/j.ejca.2010.11.004

[36]

van den Belt-Dusebout AW, Aleman BM, Besseling G, De Bruin ML, Hauptmann M, Van’t Veer MB, de WR, Ribot JG, Noordijk EM, Kerst JM, Gietema JA, van Leeuwen FE (2009) Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys 75 (5): 1420–1429. 10.1016/j.ijrobp.2009.01.073

[37]

van den Belt-Dusebout AW, de WR, Gietema JA, Horenblas S, Louwman MW, Ribot JG, Hoekstra HJ, Ouwens GM, Aleman BM, van Leeuwen FE (2007) Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 25 (28): 4370–4378. 10.1200/jco.2006.10.5296

[38]

van Leeuwen FE, Klokman WJ, Veer MB, Hagenbeek A, Krol AD, Vetter UA, Schaapveld M, van HP, Burgers JM, Somers R, Aleman BM (2000) Long-term risk of second malignancy in survivors of Hodgkin’s disease treated during adolescence or young adulthood. J Clin Oncol 18 (3): 487–497. 10.1200/jco.2000.18.3.487

[39]

The Hospital Anxiety and Depression Scale

A. S. Zigmond, R. P. Snaith

Acta Psychiatrica Scandinavica 1983 10.1111/j.1600-0447.1983.tb09716.x

Cited By

60

Stefanie Kreissl, Horst Mueller · 2016

The Lancet Oncology

Karolin Behringer, Helen Goergen · 2016

Journal of Clinical Oncology

Metrics

60

Citations

39

References

Details

Published: Jan 16, 2014
Vol/Issue: 110(4)
Pages: 868-874
License: View

Authors

L V van de Poll-Franse

Cite This Article

L A Daniëls, S Oerlemans, A D G Krol, et al. (2014). Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity. British Journal of Cancer, 110(4), 868-874. https://doi.org/10.1038/bjc.2013.779

Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity

You May Also Like